Grant: Proof of Principle Program - Phase I
McGill University
$160,000.00
A Novel Injectable Chitosan Sponge Containing BMP-7 as a Therapeutic Intervention for Accelerated Bone Formation in a Critical Size Defect Rat Model
FY 2013-14
Summary
Critical size defects in bone are non-healing injuries that require a surgical intervention to induce bone formation. These injuries occur due to trauma, removal of tumors, developmental anomalies, and infections. The current golden standard is to perform a second surgical intervention to obtain autologous bone from the patient's iliac crest and graft it in the defect. The need to create a second surgical intervention increases the risk of post-surgical complications and wound infections, and requires longer hospitalizations. A minimally invasive surgery that introduces a therapeutic modality is ideal and will reduce patient risk of infection, time of hospitalization and surgical costs. In this application, we propose the use of a novel injectable chitosan sponge containing BMP-7 to induce accelerated bone growth in critical size defects in rat models. BMP-7 has been widely investigated in bone regeneration; however, it has a short half-life (30 minutes) in the body. Therefore, in order to reduce the amount needed and provide prolonged availability in-vivo, encapsulation and slow release of BMP-7 are essential. In our system high loading of BMP-7 in the sponge was achieved. The chitosan gelation occurs very rapidly (less than 1.6 seconds) upon mixing BMP-7 containing chitosan solution and a crosslinking solution. We show in a preliminary in vivo injection that the rapid gelation ensures localized insertion and minimized flow away from the site of injection. The chitosan sponge will act not only as a depot for the slow release of BMP-7 from the site of injection, but also as scaffold to promote Osteoblasts' migration and remodeling. These preliminary results incite us to believe that this injectable system is a very promising therapeutic modality for healing critical size defects in bone.
Department
Program
Proof of Principle Program - Phase I
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
308074
Name
Tabrizian Maryam
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Proof of Principle
Projecttitle
A Novel Injectable Chitosan Sponge Containing BMP-7 as a Therapeutic Intervention for Accelerated Bone Formation in a Critical Size Defect Rat Model
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$160,000
Cihrequipment2
$0
Programname2
Proof of Principle Program - Phase I
Keyworddelim
Biocompatible Injectable Sponge; Bmp-7 Delivery System; Bone Healing And Regeneration; Critical Size Defect Model In Rat; Crosslinked Chitosan Scaffold; Immunohistochemistry; In Vitro Assessment Of The Sponge; In Vivo Assessment Of The Sponge; Rapid Gelation With Guanosine 5'-Diphosphate; X-Ray And Ct-Scan
Abstract
Critical size defects in bone are non-healing injuries that require a surgical intervention to induce bone formation. These injuries occur due to trauma, removal of tumors, developmental anomalies, and infections. The current golden standard is to perform a second surgical intervention to obtain autologous bone from the patient's iliac crest and graft it in the defect. The need to create a second surgical intervention increases the risk of post-surgical complications and wound infections, and requires longer hospitalizations. A minimally invasive surgery that introduces a therapeutic modality is ideal and will reduce patient risk of infection, time of hospitalization and surgical costs. In this application, we propose the use of a novel injectable chitosan sponge containing BMP-7 to induce accelerated bone growth in critical size defects in rat models. BMP-7 has been widely investigated in bone regeneration; however, it has a short half-life (30 minutes) in the body. Therefore, in order to reduce the amount needed and provide prolonged availability in-vivo, encapsulation and slow release of BMP-7 are essential. In our system high loading of BMP-7 in the sponge was achieved. The chitosan gelation occurs very rapidly (less than 1.6 seconds) upon mixing BMP-7 containing chitosan solution and a crosslinking solution. We show in a preliminary in vivo injection that the rapid gelation ensures localized insertion and minimized flow away from the site of injection. The chitosan sponge will act not only as a depot for the slow release of BMP-7 from the site of injection, but also as scaffold to promote Osteoblasts' migration and remodeling. These preliminary results incite us to believe that this injectable system is a very promising therapeutic modality for healing critical size defects in bone.
Competitiondate
201402
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tabrizian, Maryam
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $160,000~ $0~